Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 20.54M 19.12M 17.55M 33.14M 2.26B 33.66M 225M 88.43M 1.12B 88.73M 86.78M 3.76B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 36.67M 34.13M 31.34M 59.18M 4.03B 60.1M 402M 158M 2B 158M 155M 6.72B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
04/08/17 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
15/05/17 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/02/17 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/11/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/10/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/05/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/02/16 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/02/16 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/12/15 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/12/15 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/12/15 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/11/15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/10/15 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 week+20.00%
Current month+20.00%
1 month+2.44%
3 months-19.23%
6 months-6.67%
Current year+27.27%
1 week 0
Extreme 0.0035
0
1 month 0
Extreme 0.0035
0
Current year 0
Extreme 0.0016
0.01
1 year 0
Extreme 0.0016
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 0
0.02
10 years 0
Extreme 0
0.73
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+20.00%-36.36%+100.00% 1.33M
-1.87%+4.05%+22.58%+442.96% 2.16B
+3.94%+21.26%-29.67%-53.83% 1.93B
+0.37%-3.46% - - 1.79B
-0.45%+3.23%+81.51%+480.03% 1.33B
-3.19%+8.59%-43.41%+29.26% 1.29B
-0.36%+0.08%+329.54%+913.85% 1.08B
+3.91%+6.81%+60.35%+44.83% 1.03B
+7.02%+30.23%+19.84%+64.15% 887M
+9.99%+61.06%+35.96%-38.09% 525M
Average +1.94%+9.52%+48.92%+220.35% 1.2B
Weighted average by Cap. +1.22%+7.64%+48.77%+254.19%

Financials

2015 2016
Net sales 25.48M 22.15M 20.62M 18.93M 35.75M 2.43B 36.3M 243M 95.38M 1.21B 95.7M 93.59M 4.06B 32.33M 28.1M 26.16M 24.02M 45.35M 3.09B 46.06M 308M 121M 1.54B 121M 119M 5.15B
Net income 5.49M 4.78M 4.45M 4.08M 7.71M 525M 7.83M 52.41M 20.57M 261M 20.64M 20.18M 876M 2.06M 1.79M 1.67M 1.53M 2.89M 197M 2.94M 19.66M 7.72M 97.96M 7.74M 7.57M 328M
Net Debt 24.8M 21.56M 20.07M 18.43M 34.8M 2.37B 35.34M 237M 92.85M 1.18B 93.16M 91.11M 3.95B 18.56M 16.13M 15.02M 13.79M 26.04M 1.77B 26.44M 177M 69.47M 882M 69.7M 68.17M 2.96B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
27/07/26 $0.003500 -.--% 70,000
  1. Stock Market
  2. Stocks
  3. AOXG Stock